ISMRM & ISMRT Annual Meeting & Exhibition • 10-15 May 2025 • Honolulu, Hawai'i

ISMRM & ISMRT 2025 Annual Meeting & Exhibition

Digital Poster

CEST, APT, & NOE

Navigation: Back to Meeting HomeBack to Meeting Home Navigation: Back to Program-at-a-GlanceBack to the Program-at-a-Glance

CEST, APT, & NOE
Digital Poster
Contrast Mechanisms
Tuesday, 13 May 2025
Exhibition Hall
08:15 -  09:15
Session Number: D-92
No CME/CE Credit

 
Computer Number: 33
2293. B1 inhomogeneity mitigated chemical exchange saturation transfer imaging using tailored saturation pulses
J. Tang, Y. Zhang
Key Laboratory for Biomedical Engineering of Ministry of Education, Department of Biomedical Engineering, College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, China
Impact: A new method to mitigate the influence of B1 inhomogeneity for CEST imaging is provided. The method has the advantage of being easy to implement and not increasing the acquisition duration.
 
Computer Number: 34
2294. Experimental study on evaluating renal redox metabolism in renal ischemia-reperfusion injury using GluCEST imaging with 3.0 T MRI
L. Liu, W. Mi, X. Yu, W. Xing, L. Pan
Third Affiliated Hospital of Soochow University, ChangZhou, China
Impact:

This study demonstrates that GluCEST is a noninvasive and reliable imaging technique that evaluates the renal redox metabolism status after IRI and aids in the early diagnosis and clinical management of renal IRI.

 
Computer Number: 35
2295. Multicenter Validation of Amide Proton Transfer Imaging for Molecular and Grade Classification of Adult-Type Diffuse Gliomas
T. Jiang, M. Wu, J. Hu, Y. Hsu, H. Guo, X. Ma, Y. Liu, Y. Zhang
Zhejiang University, Hangzhou, China
Impact: This study demonstrates that APT imaging reliably differentiates adult-type gliomas across centers, enabling more precise, non-invasive tumor characterization. It promotes earlier, molecularly informed diagnoses, guiding personalized treatment strategies and fostering research on APT imaging's prognostic and therapeutic potential.
 
Computer Number: 36
2296. Enhancing SNR of CEST MRI Through Noise-to-Noise Deep Learning with K-space Data Consistency
H. LIU, Z. XIA, L. H. LAW, Z. CHEN, J. HUANG, D. SHEN, K. CHAN
City University of Hong Kong, Hong Kong, China
Impact: Our method can considerably increase SNR of CEST images without sacrificing image fidelity. After denoising, the derived CEST maps could more reliably represent molecular changes in brain regions.
 
Computer Number: 37
2297. Mitigation of T1 impact for unbiased tumor APT MRI using quasi-steady-state based apparent exchange-dependent relaxation analysis
Z. Liu, Q. Yang, H. Liu, H. Luo, Y. Zheng, W. Cui, D. Luo, Y. Wu
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
Impact: The QUASS-based AREX analysis can effectively correct the T1 confoundment in CEST measurements, facilitating unbiased tumor CEST MRI at 3 T.
 
Computer Number: 38
2298. CEST contrasts remain stable in normal-appearing brain tissues but reveal tumor-specific alterations after radiotherapy in glioma patients
S. Regnery, N. von Knebel Döberitz, F. Kroh, P. Boyd, P. Menshchikov, S. Graß, C. Bauspieß, M. Ladd, J. Debus, H-P Schlemmer, A. Korzowski, L. König, D. Paech
Heidelberg University Hospital, Heidelberg, Germany
Impact: CEST contrasts remain unchanged in normal-appearing brain tissue after radiotherapy but change inside gliomas. Based on these findings, CEST contrast changes in gliomas after radiotherapy should be considered to be tumor-specific, and may be used to support tumor response assessment.
 
Computer Number: 39
2299. Oxidative Phosphorylation in Skeletal Muscle Measured by High-Temporal-Resolution CEST MRI at 3T
L. Ju, T. Samuel, M. Schär, K. Wang, Y. Wu, R. Weiss, J. Xu
Johns Hopkins University, Baltimore, United States
Impact: With temporal resolution comparable to the 31P MRS technique, UFZ MRI shows great potential as a robust tool for non-invasive, localized assessment of mitochondrial function in skeletal muscles, which will assist the diagnosis of related diseases.
 
Computer Number: 40
2300. CEST fluid artifact identification by steady-state signal fitting (FISS)
X. Yong, L. Zhou, C. Zhang, Y-C Hsu, C. Su, S. Lu, Y. Zhang
Zhejiang University, Hangzhou, China
Impact: The proposed method shows the ability to identify the fluid compartments on CEST images,which can help mitigate fluid artifacts in quantitative analysis and improve image reading.
 
Computer Number: 41
2301. CEST analysis using a deep residual learning method based on Bloch-McConnell synthetic training data
S. Zeng, H. Zhang, Z. Wang, J. Wang, P. Cai, J. Huang
the University of Hong Kong, Hong Kong, China
Impact: We proposed deep residual networks to predict the Z-spectrum reference signal (ZrefNet) for CEST quantification. ZrefNet generated accurate CEST contrasts on simulation data and demonstrated its feasibility for analyzing in vivo human CEST data of multiple sclerosis and healthy controls.
 
Computer Number: 42
2302. The Value of Amide Proton Transfer MRI in the Grading of Clear Cell Renal Cell Carcinoma : Comparison With Diffusion-Weighted Imaging
X. Yang, H. Gao, C. Shen, Y. Fan, C. Zhang, D. Liu, P. Wu, L. Han, Y. Bai
Liaocheng People's Hospital, Liaocheng, China
Impact: APTw MRI holds potential as a valuable supplementary sequence to conventional MRI for the grading of ccRCC.
 
Computer Number: 43
2303. Magnetic Resonance Fingerprinting for Glutamate Quantification: Towards the Intermediate Exchange Regime
D. Korenchan, N. Vladimirov, O. Perlman, C. Farrar
Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, United States
Impact: We demonstrate the initial development of quantitative glutamate imaging using chemical exchange and fingerprinting, which offers higher spatial resolution than spectroscopy and can track disease-dependent glutamate changes in the brain, such as for cancer or neurodegeneration.
 
Computer Number: 44
2304. 31P-CEST “matrix” for in vivo rat brain: novel apparent Z spectra analysis towards sensitive imaging
N. Gao, Y. Wang, J-H Gao, X. Song
Center for Biomedical Imaging Research, Tsinghua University, Beijing, China
Impact: This study demonstrates that 31P-CEST technique enables the detection of individual metabolites (several mM) by indirectly detecting the bulk 31P signal (~20 mM), indicating the potential of 31P-CEST-MRI for accelerating acquisition and enhancing sensitivity by removing the spectral dimension.
 
Computer Number: 45
2305. Histogram Analysis of 3D Amide Proton Transfer-weighted MRI for Distinguishing Brain Abscesses from Cystic High-grade Gliomas
X. Zou, Y. Xu, Z. Wen
Zhujiang Hospital of Southern Medical University, Guangzhou, China
Impact:  This study is the first to utilize APTw imaging to differentiate between brain abscesses and cystic high-grade gliomas. The results highlight the potential of APTw as a valuable imaging biomarker, supporting its utility in improving diagnostic accuracy.
 
Computer Number: 46
2306. APTw-MRI with additional suppression of fluid compartments (necrosis) and noise reduction using rescaled MT-correcting CEST metrics
J. Keupp, O. Togao
Philips Innovative Technologies, Hamburg, Germany
Impact: The rescaled metric may provide a standard for displaying APTw contrast in tumor diagnosis and response assessment, combining MT-corrected and low noise quantitative assessment of chemical exchange in solid tumor areas with extra fluid suppression for efficient clinical reading.
 
Computer Number: 47
2307. R1rho Dispersion Imaging to Detect Proteoglycan Loss in the Intervertebral Discs in Swine Models
M. Christiansen, S. Perez, M. Preul, J. Turner, J. Uribe, E. Mufson, D. Yang, W. Yoo, J. Gore, R. Dortch, P. Wang
Barrow Neurological Institute, Phoenix, United States
Impact: The study suggested that R1rho dispersion can detect the proteoglycan loss in spine discs, potentially making it a promising tool for the early detection of disc degeneration.
 
Computer Number: 48
2308. Differentiating glioma recurrence and pseudoprogression by APTw CEST MRI
K. Karimian-Jazi, N. Enbergs, E. Golubtsov, K. Schregel, J. Ungermann, H. Fels-Palesandro, D. Schwarz, V. Sturm, J. Kernbach, D. Batra, F. Ippen, I. Pflüger, N. von Knebel Doeberitz, S. Heiland, M. Platten, F. Winkler, W. Wick, D. Paech, M. Bendszus, M. Breckwoldt
University Hospital Heidelberg, Heidelberg, Germany
Impact: This study highlights APTw-CEST MRI's value as an imaging biomarker, aiding clinicians in differentiating progression from pseudoprogression. It enables targeted treatment strategies and opens new research into metabolic imaging for personalized glioma management, enhancing patient care and guiding therapy decisions.
Similar Session(s)

Navigation: Back to Meeting HomeBack to Meeting Home Navigation: Back to Program-at-a-GlanceBack to the Program-at-a-Glance

The International Society for Magnetic Resonance in Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.